Corvus Pharmaceuticals, Inc.
CRVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626971
No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Corvus Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- 0 vs. Q1 2024
- Shares held
- 27.6M
- +9.69M (+54.1%) vs. Q1 2024
- Total value
- $50.2M
- +$18.4M (+57.6%) vs. Q1 2024
- New holders
- 7
- 12 more added
- Sold out
- 7
- 10 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 173 | $1.06B |
| Q1 2026 | 164 | $1.02B |
| Q4 2025 | 124 | $359.4M |
| Q3 2025 | 103 | $312.7M |
| Q2 2025 | 92 | $167.1M |
| Q1 2025 | 88 | $115.4M |
| Q4 2024 | 86 | $202.0M |
| Q3 2024 | 62 | $158.5M |
| Q2 2024 | 47 | $50.2M |
| Q1 2024 | 47 | $31.9M |
| Q4 2023 | 48 | $33.8M |
| Q3 2023 | 52 | $28.0M |
| Q2 2023 | 52 | $44.6M |
| Q1 2023 | 37 | $18.9M |
| Q4 2022 | 42 | $18.2M |
| Q3 2022 | 48 | $18.1M |
| Q2 2022 | 47 | $25.4M |
| Q1 2022 | 57 | $44.9M |
| Q4 2021 | 62 | $66.7M |
| Q3 2021 | 61 | $136.4M |
| Q2 2021 | 50 | $63.2M |
| Q1 2021 | 49 | $62.8M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Corvus Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 6,943,654 | $12.6M | 0.27% | 00.0% | Unchanged |
| Samlyn Capital, LLC | 6,123,021 | $11.1M | 0.19% | +3,774,658+160.7% | Added |
| Point72 Asset Management, L.P. | 5,964,510 | $10.9M | 0.04% | +5,964,510 | New |
| Adams Street Partners LLC | 3,275,616 | $5.96M | 2.46% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,650,500 | $3.00M | 0.00% | +157,143+10.5% | Added |
| Renaissance Technologies LLC | 563,932 | $1.03M | 0.00% | −73,100−11.5% | Reduced |
| BlackRock Inc. | 562,024 | $1.02M | 0.00% | +39,046+7.5% | Added |
| Geode Capital Management, LLC | 460,140 | $837.6K | 0.00% | +88,377+23.8% | Added |
| Towerview LLC | 400,000 | $728.0K | 0.48% | +17,500+4.6% | Added |
| Morgan Stanley | 371,403 | $676.0K | 0.00% | +96,042+34.9% | Added |
| Millennium Management LLC | 204,598 | $372.4K | 0.00% | +181,317+778.8% | Added |
| Bridgeway Capital Management, LLC | 127,300 | $231.7K | 0.01% | −97,000−43.2% | Reduced |
| State Street Corp | 120,303 | $219.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 113,400 | $206.4K | 0.00% | −71,700−38.7% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 83,222 | $151.5K | 0.00% | −4,786−5.4% | Reduced |
| Northern Trust Corp | 82,990 | $151.0K | 0.00% | +18,041+27.8% | Added |
| Marshall Wace, LLP | 74,559 | $135.7K | 0.00% | +74,559 | New |
| Jackson Square Capital, LLC | 63,773 | $116.1K | 0.03% | 00.0% | Unchanged |
| Citadel Advisors LLC | 53,010 | $96.5K | 0.00% | +53,010 | New |
| Hikari Power Ltd | 49,959 | $91.0K | 0.01% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 47,786 | $87.0K | 0.00% | −54,663−53.4% | Reduced |
| Susquehanna International Group, LLP | 25,650 | $46.7K | 0.00% | −79,376−75.6% | Reduced |
| Cubist Systematic Strategies, LLC | 24,364 | $44.3K | 0.00% | +24,364 | New |
| Quinn Opportunity Partners LLC | 22,327 | $40.6K | 0.00% | 00.0% | Unchanged |
| Commerce Bank | 20,000 | $36.4K | 0.00% | 00.0% | Unchanged |
| American Century Companies Inc | 18,248 | $33.2K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 15,668 | $28.5K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 15,300 | $27.8K | 0.00% | +3,789+32.9% | Added |
| Resources Investment Advisors, LLC. | 14,550 | $26.5K | 0.00% | −3,400−18.9% | Reduced |
| UBS Group AG | 13,000 | $23.7K | 0.00% | +8,321+177.8% | Added |
| Dimensional Fund Advisors LP | 11,924 | $21.7K | 0.00% | 00.0% | Unchanged |
| Gillespie Robinson & Grimm Inc | 11,580 | $21.1K | 0.00% | +100+0.9% | Added |
| Two Sigma Securities, LLC | 11,384 | $20.7K | 0.00% | +11,384 | New |
| Whittier Trust Co of Nevada Inc | 11,200 | $20.3K | 0.00% | 00.0% | Unchanged |
| Masso Torrence Wealth Management Inc. | 10,000 | $18.2K | 0.01% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 9,152 | $16.7K | 0.00% | −43,672−82.7% | Reduced |
| Royal Bank of Canada | 7,238 | $13.0K | 0.00% | +7,238 | New |
| Rothschild Investment LLC | 7,000 | $12.7K | 0.00% | 00.0% | Unchanged |
| Northwest Capital Management Inc | 3,397 | $6.18K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 2,212 | $4.00K | 0.00% | −7,134−76.3% | Reduced |
| Rhumbline Advisers | 791 | $1.44K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 534 | $971 | 0.00% | −666−55.5% | Reduced |
| Bank of America Corp | 392 | $713 | 0.00% | +392 | New |
| FMR LLC | 53 | $96 | 0.00% | +36+211.8% | Added |
| IFP Advisors, Inc | 24 | $44 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 20 | $36 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| BVF Inc | 0 | $0 | 0.00% | −361,406−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,570−100.0% | Sold out |
| Fortem Financial Group, LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −4,604−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −2,378−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −265−100.0% | Sold out |
| ICA Group Wealth Management, LLC | 0 | $0 | 0.00% | −165−100.0% | Sold out |